~~<i id='6D552F5F0D'><strike id='6D552F5F0D'><tt id='6D552F5F0D'><pre id='6D552F5F0D'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：fashion 2025-09-27 15:17:34 Page View：1636

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How many hemophilia patients actually want gene therapy?
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

explore

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Ebola vaccine can save some who are already sick, per new study

Anewstudyshowsthatinadditiontopreventinginfections,theEbolavaccinecansavesomepeoplewhoarealreadysick

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

EPA limits use of carcinogenic gas for sterilizing medical devices

TheagencyfirstproposedlimitsonthegasinApril2023,withthegoalofreducingemissionsby80%.Now,theagencyisp